BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37352875)

  • 1. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
    Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
    Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
    Schrag D; Beer TM; McDonnell CH; Nadauld L; Dilaveri CA; Reid R; Marinac CR; Chung KC; Lopatin M; Fung ET; Klein EA
    Lancet; 2023 Oct; 402(10409):1251-1260. PubMed ID: 37805216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
    Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
    Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeled residual current cancer risk after clinical investigation of a positive multicancer early detection test result.
    Hudnut AG; Hubbell E; Venn O; Church TR
    Cancer; 2023 Jul; 129(13):2056-2063. PubMed ID: 36943898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
    Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
    Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing positive multi-cancer early detection tests in head and neck Surgery: Experience with head and neck work up for high-risk referrals.
    Fearington FW; Zhao CY; Romero-Brufau S; Moore EJ; Price DL; Tasche KK; Yin LX; Kunkel ET; Kisiel JB; Giridhar KV; Routman DM; Van Abel KM
    Oral Oncol; 2024 May; 152():106809. PubMed ID: 38621326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
    Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
    Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-year clinical outcomes of cancers diagnosed following detection by a blood-based multi-cancer early detection (MCED) test.
    Buchanan AH; Lennon AM; Choudhry OA; Elias PZ; Rego SP; Sadler JR; Roberta J; Zhang Y; Flake DD; Salvati ZM; Wagner ES; Fishman EK; Papadopoulos N; Beer TM
    Cancer Prev Res (Phila); 2024 May; ():. PubMed ID: 38819783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
    Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
    Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study.
    Luan Y; Zhong G; Li S; Wu W; Liu X; Zhu D; Feng Y; Zhang Y; Duan C; Mao M
    EClinicalMedicine; 2023 Jul; 61():102041. PubMed ID: 37387788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England.
    Smittenaar R; Quaife SL; von Wagner C; Higgins T; Hubbell E; Lee L
    J Epidemiol Community Health; 2024 May; 78(6):345-353. PubMed ID: 38429085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
    Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
    Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity.
    Tang WHW; Yimer H; Tummala M; Shao S; Chung G; Clement J; Chu BC; Hubbell E; Kurtzman KN; Swanton C; Roberts LR
    Prev Med; 2023 Feb; 167():107384. PubMed ID: 36495927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
    Schmeising-Barnes N; Waller J; Marlow LAV
    Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED study.
    Lennon AM; Buchanan AH; Rego SP; Choudhry OA; Elias PZ; Sadler JR; Roberta J; Zhang Y; Flake DD; Honushefsky A; Salvati ZM; Sheridan K; Wagner ES; Fishman EK; Papadopoulos N; Beer TM
    Cancer Prev Res (Phila); 2024 May; ():. PubMed ID: 38705577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
    Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
    Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.